ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01598831
Recruitment Status : Active, not recruiting
First Posted : May 15, 2012
Last Update Posted : March 23, 2018
Sponsor:
Information provided by (Responsible Party):
Asahi Kasei Pharma America Corporation

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : August 2018
  Estimated Study Completion Date : July 2019